Dr. Thompson is a Urologic Oncologist who retired in December 2016 as the Director of the Cancer Treatment Research Center and now serves as President of CHRISTUS Santa Rosa Medical Center Hospital and Vice President of Oncology Services for CHRISTUS Santa Rosa.  He is Past-President of the American Board of Urology, was a former President of the Society of Urologic Oncology, and in February 2017 will join the Board of Scientific Advisors of the National Cancer Institute. He has led multiple major national clinical trials for the National Cancer Institute including the Prostate Cancer Prevention Trial, an 18,882-subject study published in 2003 that showed that finasteride reduces the risk of prostate cancer by 30%.  His more than 600 publications since 1980 have changed the way urologic cancers are treated around the world.